GSA Capital Partners’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47M Buy
187,337
+146,659
+361% +$3.27M 0.16% 99
2026
Q1
$1.07M Buy
40,678
+40,030
+6,177% +$5.03M 0.07% 459
2025
Q4
$161K Sell
648
-1,737
-73% -$397K 0.01% 1463
2025
Q3
$502K Sell
2,385
-7,121
-75% -$1.26M 0.04% 845
2025
Q2
$935K Buy
9,506
+812
+9% +$70.8K 0.07% 504
2025
Q1
$765K Sell
8,694
-2,086
-19% -$193K 0.07% 514
2024
Q4
$780K Buy
10,780
+9,936
+1,177% +$681K 0.06% 574
2024
Q3
$67K Buy
+844
New +$65K 0.01% 1510
2023
Q3
– Sell
-6,060
Closed -$582K – 1650
2023
Q2
$582K Buy
6,060
+5,742
+1,806% +$572K 0.06% 647
2023
Q1
$32K Sell
318
-1,263
-80% -$193K ﹤0.01% 1414
2022
Q4
$274K Buy
1,581
+1,065
+206% +$701K 0.03% 997
2022
Q3
$494K Buy
516
+243
+89% +$241K 0.07% 579
2022
Q2
$183K Buy
273
+27
+11% +$16.7K 0.03% 1093
2022
Q1
$171K Buy
+246
New +$190K 0.02% 1209
2021
Q4
– Sell
-132
Closed -$133K – 1555
2021
Q3
$133K Buy
+132
New +$97.2K 0.01% 1296
2021
Q2
– Sell
-481
Closed -$356K – 1418
2021
Q1
$356K Buy
+481
New +$388K 0.06% 546
2020
Q4
– Sell
-793
Closed -$788K – 1353
2020
Q3
$788K Buy
793
+618
+353% +$655K 0.13% 178
2020
Q2
$182K Sell
175
-276
-61% -$278K 0.1% 374
2020
Q1
$366K Buy
+451
New +$471K 0.09% 347

Other funds holding GOSS

GSA Capital Partners's GOSS Position: Q2 2026 in Review

GSA Capital Partners increased its Gossamer Bio (GOSS) stake by 361% in Q2 2026, buying an estimated $3.27M and bringing the position to 187,337 shares worth $2.47M. The position accounts for 0.16% of the portfolio, ranked #99.

GSA Capital Partners first reported a position in GOSS in Q1 2020 and has held it in 19 quarters since. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • GSA Capital Partners held 187,337 shares of Gossamer Bio worth $2.47M as of Q2 2026.
  • GSA Capital Partners bought 146,659 Gossamer Bio shares in Q2 2026, an estimated $3.27M.
  • Gossamer Bio made up 0.16% of GSA Capital Partners's portfolio in Q2 2026, its #99 holding.
  • GSA Capital Partners first reported a position in Gossamer Bio in Q1 2020 and has held it in 19 quarters since.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.